This inventor holds 4 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: Saniona A/s. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Innovations by Thomas Amos Jacobsen: A Leader in Hypertension Treatment
Introduction
Thomas Amos Jacobsen, an innovative inventor based in Glostrup, Denmark, has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hypertension. With a total of three patents to his name, Jacobsen has demonstrated a strong commitment to developing effective therapies that address critical health issues.
Latest Patents
Jacobsen's recent inventions include groundbreaking advancements in the treatment of hypertension. One of his notable patents involves the use of tesofensine and metoprolol, which specifically targets the treatment of hypertension in obese and diabetic patients. This combination therapy is aimed at providing a more effective solution for those who struggle with both hypertension and weight-related health challenges.
Additionally, Jacobsen has patented novel potassium channel inhibitors. This invention encompasses unique compounds and pharmaceutical compositions designed to treat, alleviate, or prevent conditions related to the activity of potassium channels, further expanding the therapeutic possibilities in cardiovascular and metabolic health.
Career Highlights
Throughout his career, Thomas Amos Jacobsen has played a pivotal role at Saniona A/S, a company known for its innovative approaches in the biotechnology sector. His dedication to research and development continues to pave the way for advancements in treatments that address pressing health concerns.
Collaborations
Jacobsen collaborates with esteemed colleagues, including Janus Schreiber Larsen and Dipak Amrutkar. Together, they contribute to the drug development process, sharing their expertise and insights to enhance the efficacy and safety of new therapeutic approaches.
Conclusion
Thomas Amos Jacobsen's contributions to the field of hypertension treatment exemplify the impact of dedicated innovators in the medical industry. His patents not only reflect his expertise but also hold the potential to improve the lives of many individuals suffering from hypertension and related disorders. Jacobsen’s work at Saniona A/S, alongside his talented coworkers, marks a significant advancement in the ongoing battle against chronic health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile